Related Experiment Video
Updated: Mar 7, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-520c enhances cell proliferation, migration, and invasion by suppressing IRF2 in gastric cancer
Ying-Ru Li1, Li-Qiang Wen2, Yang Wang3
1Department of Gastroenterology Hernia and Abdominal Wall Surgery The Sixth Affiliated Hospital of Sun Yat-Sen University Guangzhou China.
Abstract:
Dysregulation of microRNA (miRNA) is actively involved in the development and progression of gastric cancer (GC). MiR-520c was previously found to be overexpressed in GC specimens and cells. However, the clinical significance of miR-520c and its biological function in GC remain largely unknown. Here, we found that miR-520c expression in GC tissues was significantly increased compared to normal adjacent gastric tissues. Its increased level was prominently correlated with poor clinical parameters and prognosis of GC patients. Accordingly, the expression of miR-520c was obviously elevated in GC cell lines as compared with gastric epithelial cells. Overexpression of miR-520c in N-87 cells significantly increased the proliferative ability, migration, and invasion of cancer cells, while miR-520c silencing suppressed MKN-45 cell proliferation, migration, and invasion in vitro. Mechanically, miR-520c inversely regulated interferon regulatory factor 2 (IRF2) abundance in GC cells. Herein, IRF2 was found to be a downstream target of miR-520c in GC. Furthermore, IRF2 was down-regulated in GC tissues compared to nontumor tissues. An inverse correlation between IRF2 and miR-520c expression was observed in GC cases. Taken together, miR-520c may serve as a prognostic predictor and a therapeutic target for GC patients.
Insights
MicroRNA 520c (miR-520c) is overexpressed in gastric cancer (GC), promoting tumor growth and invasion. This microRNA may serve as a valuable prognostic marker and therapeutic target for GC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA (miRNA) dysregulation is implicated in gastric cancer (GC) development.
- MiR-520c is known to be overexpressed in GC, but its clinical significance and function are unclear.
Purpose of the Study:
- To investigate the clinical significance and biological function of miR-520c in gastric cancer.
- To explore the underlying molecular mechanisms of miR-520c in GC progression.
Main Methods:
- Quantitative real-time PCR to measure miR-520c and IRF2 expression in GC tissues and cell lines.
- In vitro gain-of-function and loss-of-function assays to assess the effects of miR-520c on GC cell proliferation, migration, and invasion.
- Western blot analysis to determine protein levels of IRF2.
Main Results:
- MiR-520c expression was significantly elevated in GC tissues and cell lines compared to normal tissues and cells.
- High miR-520c levels correlated with poor clinical parameters and prognosis in GC patients.
- Overexpression of miR-520c promoted GC cell proliferation, migration, and invasion, while silencing miR-520c inhibited these processes.
- MiR-520c directly targeted and inversely regulated interferon regulatory factor 2 (IRF2) expression.
- IRF2 was found to be downregulated in GC tissues, with an inverse correlation to miR-520c levels.
Conclusions:
- MiR-520c plays a crucial role in promoting gastric cancer progression by targeting IRF2.
- MiR-520c may serve as a potential prognostic biomarker and therapeutic target for gastric cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia
Experimental RNAi
Cell Migration

